patents

Generic savings tell a different patent-loss tale

Generic savings tell a different patent-loss tale

Fierce Pharma

Vivus Holds Strong Patent Portfolio For Qsymia

Vivus Holds Strong Patent Portfolio For Qsymia

Seeking Alpha

Report Raising Vivus Qsymia Patent Infringement Concerns Was Not Competent

Report Raising Vivus Qsymia Patent Infringement Concerns Was Not Competent

Seeking Alpha

Illumina countersues Intelligent Bio-Systems and Qiagen

Illumina countersues Intelligent Bio-Systems and Qiagen

Reuters

Vivus falls on concerns of patent protection for diet pill

Vivus falls on concerns of patent protection for diet pill

Reuters

Court upholds Pfizer's Lyrica patent protection

Court upholds Pfizer's Lyrica patent protection

Reuters

Merck: Experts In Patent Cliff Management

Merck: Experts In Patent Cliff Management

Motley Fool

Why Big Pharma Won't Get Its Piece Of The $1.2 Trillion Global Drug Market

Why Big Pharma Won't Get Its Piece Of The $1.2 Trillion Global Drug Market

Forbes

Pfizer Is Worth $25 Despite Lawsuits And Lipitor Patent Expiry

Pfizer Is Worth $25 Despite Lawsuits And Lipitor Patent Expiry

Forbes

3 Things to Watch With Gilead Sciences

3 Things to Watch With Gilead Sciences

Motley Fool